HUTCHMED (China) (HCM) Treasury Shares (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Treasury Shares came in at -$36.1 million in Q4 2024, down 297.57% year-on-year from $18.3 million in Q1 2024, and little changed on a QoQ basis from -$36.1 million in Q2 2024.
HUTCHMED (China) (HCM) Treasury Shares (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 10 years of Treasury Shares data on file, last reported at -$36.1 million in Q4 2024.
- On a quarterly basis, Treasury Shares fell 297.57% year-over-year to -$36.1 million in Q4 2024; TTM through Dec 2024 was -$36.1 million, a 297.57% decrease from a year earlier, with the FY2024 full-year figure at -$36.1 million, down 297.57% from the prior year.
- Treasury Shares for Q4 2024 stood at -$36.1 million, roughly flat from -$36.1 million in the prior quarter.
- Over the last five years, Treasury Shares for HCM reached as high as $2.5 million in Q4 2022 and fell as low as $1.0 million in Q4 2021.
- Historically, Treasury Shares has averaged $1.9 million across 5 years, with a median of $2.2 million in 2024.
- Across the five-year window, Treasury Shares plunged 3629.48% in 2020 and surged 81.14% in 2023, its largest moves.
- Year by year, Treasury Shares stood at -$12.9 million in 2020, then sank by 111.63% to -$27.3 million in 2021, then slumped by 76.07% to -$48.1 million in 2022, then jumped by 81.14% to -$9.1 million in 2023, then slumped by 297.57% to -$36.1 million in 2024.
- Per Business Quant data, the three most recent Treasury Shares figures were -$36.1 million in Q4 2024, -$36.1 million in Q2 2024, and -$9.1 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2025 | 1.62 Mn |
| Dec 31, 2024 | -36.06 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | -36.06 Mn |
| Jun 30, 2024 | -36.06 Mn |
| Jun 30, 2024 | -36.06 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Dec 31, 2023 | 2.25 Mn |
| Dec 31, 2023 | -9.07 Mn |
| Dec 31, 2023 | -9.07 Mn |
| Jun 30, 2023 | -9.07 Mn |
| Jun 30, 2023 | -9.07 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Dec 31, 2022 | -48.08 Mn |
| Dec 31, 2022 | -48.08 Mn |
| Jun 30, 2022 | -48.08 Mn |
| Jun 30, 2022 | -48.08 Mn |